BOSTON SCIENTIFIC CORPORATION Supplier Finance Program Obligation
BOSTON SCIENTIFIC CORPORATION (BSX) had Supplier Finance Program Obligation of $144.00 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Balance Sheet › Liabilities
us-gaap:SupplierFinanceProgramObligation · last filed 2026-02-17
- 2025-12-31: Supplier Finance Program Obligation $144.00M.
- 2024-12-31: Supplier Finance Program Obligation $140.00M.
- 2023-12-31: Supplier Finance Program Obligation $152.00M.
- 2022-12-31: Supplier Finance Program Obligation $129.00M.
| Period end | Supplier Finance Program Obligation |
|---|---|
| 2025-12-31 | $144.00M 10-K · filed 2026-02-17 |
| 2024-12-31 | $140.00M 10-K · filed 2026-02-17 |
| 2023-12-31 | $152.00M 10-K · filed 2025-02-18 |
| 2022-12-31 | $129.00M 10-K · filed 2024-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |